Gentamicin in pharmacogenetic approach to treatment of cystic fibrosis

被引:10
作者
Hamilton, JW [1 ]
机构
[1] Dartmouth Coll, Sch Med, Environm Hlth Sci Ctr, Dartmouth Tox Met Res Program, Hanover, NH 03755 USA
关键词
D O I
10.1016/S0140-6736(01)07138-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2014 / 2016
页数:3
相关论文
共 17 条
[1]   REGULATION OF ION CHANNELS BY ABC TRANSPORTERS THAT SECRETE ATP [J].
ALAWQATI, Q .
SCIENCE, 1995, 269 (5225) :805-806
[2]   Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice [J].
Barton-Davis, ER ;
Cordier, L ;
Shoturma, DI ;
Leland, SE ;
Sweeney, HL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) :375-381
[3]   Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line [J].
Bedwell, DM ;
Kaenjak, A ;
Benos, DJ ;
Bebok, Z ;
Bubien, JK ;
Hong, J ;
Tousson, A ;
Clancy, JP ;
Sorscher, EJ .
NATURE MEDICINE, 1997, 3 (11) :1280-1284
[4]   Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis [J].
Clancy, JP ;
Bobök, Z ;
Ruiz, F ;
King, C ;
Jones, J ;
Walker, L ;
Greer, H ;
Hong, J ;
Wing, L ;
Macaluso, M ;
Lyrene, R ;
Sorscher, EJ ;
Bedwell, DM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (07) :1683-1692
[5]   Cystic fibrosis [J].
Davis, PB ;
Drumm, M ;
Konstan, MW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) :1229-1256
[6]   A(1) RECEPTOR ANTAGONIST 8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE SELECTIVELY ACTIVATES CHLORIDE EFFLUX FROM HUMAN EPITHELIAL AND MOUSE FIBROBLAST CELL-LINES EXPRESSING THE CYSTIC-FIBROSIS TRANSMEMBRANE REGULATOR DELTA-F508 MUTATION [J].
GUAYBRODER, C ;
JACOBSON, KA ;
BARNOY, S ;
CABANTCHIK, ZI ;
GUGGINO, WB ;
ZEITLIN, PL ;
TURNER, RJ ;
VERGARA, L ;
EIDELMAN, O ;
POLLARD, HB .
BIOCHEMISTRY, 1995, 34 (28) :9079-9087
[7]   Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations [J].
Howard, M ;
Frizzell, DM ;
Bedwell, DM .
NATURE MEDICINE, 1996, 2 (04) :467-469
[8]   Increased functional cell surface expression of CFTR and ΔF508-CFTR by the anthracycline doxorubicin [J].
Maitra, R ;
Shaw, CM ;
Stanton, BA ;
Hamilton, JW .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (05) :C1031-C1037
[9]   Effects of membrane potential versus pH(i) on the cellular retention of doxorubicin analyzed via a comparison between cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance (MDR) transfectants [J].
Robinson, LJ ;
Roepe, PD .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (07) :1081-1095
[10]   In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing Delta F508-CFTR [J].
Rubenstein, RC ;
Egan, ME ;
Zeitlin, PL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2457-2465